Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SpectrumAi is a healthcare technology company dedicated to improving the quality and outcomes of Applied Behavior Analysis (ABA) therapy for individuals with Autism Spectrum Disorder (ASD). The company's flagship platform, Twine, utilizes data analytics to capture and analyze clinical data from ABA sessions, providing actionable insights for both healthcare providers and payers. By standardizing data collection and benchmarking performance, SpectrumAi aims to transition the ABA industry toward value-based care models. The company focuses on enhancing transparency, clinical efficacy, and access to care for the neurodiverse community. Their solutions help bridge the gap between clinical delivery and insurance reimbursement through objective, data-driven metrics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SpectrumAi.